- Published on
Oncology-External Beam Radiotherapy: Progress & Techniques
This study guide summarizes advancements in external beam radiotherapy, focusing on 3D planning and conformal treatment.
I. Three-Dimensional (3D) Radiotherapy Planning:
II. Conformal Treatment and Multileaf Collimators (MLCs):
This study guide summarizes advancements in external beam radiotherapy, focusing on 3D planning and conformal treatment.
I. Three-Dimensional (3D) Radiotherapy Planning:
- Revolutionizing Factor: The most significant advancement in the last 20 years is the integration of cross-sectional imaging (primarily CT scans) into radiotherapy planning. This shift enables:
- Accurate Target Definition: Precise delineation of tumors and critical structures.
- Precise Dose Calculation: More accurate determination of radiation dosage.
- True 3D Planning: Allows for:
- Reduced Normal Tissue Damage: Minimizing harm to healthy tissue.
- Increased Tumor Dose: Delivering higher radiation doses to the cancerous target.
- Improved Therapeutic Index: Optimizing the balance between tumor control and side effects.
II. Conformal Treatment and Multileaf Collimators (MLCs):
- Goal: The primary goal of radiotherapy has always been to precisely conform the high-dose radiation to the target tumor while sparing surrounding healthy tissue.
- Traditional Limitations: Until the 1990s, rectangular beams with limited blocking techniques resulted in unnecessary irradiation of normal tissue.
- Advancements:
- Shaped Alloy Blocks: Improved conformation by manually placing shaped blocks to partially obstruct the radiation beam.
- Multileaf Collimators (MLCs): A significant advancement integrated into modern linear accelerators. MLCs allow for computer-controlled shaping of the radiation beam using numerous 0.5cm-wide leaves. This enables highly precise shaping of the radiation field.
- Clinical Significance: By minimizing high-dose radiation to normal tissue, MLCs enable higher radiation doses to the tumor, potentially improving tumor control without increasing the risk of side effects (morbidity).
0 Comments